Literature DB >> 19360909

MicroRNA signatures in liver diseases.

Xian-Ming Chen.   

Abstract

MicroRNAs (miRNAs) are an emerging class of highly conserved non-coding small RNAs that regulate gene expression at the post-transcriptional level. It is now clear that miRNAs can potentially regulate every aspect of cellular activity, including differentiation and development, metabolism, proliferation, apoptotic cell death, viral infection and tumorigenesis. Recent studies provide clear evidence that miRNAs are abundant in the liver and modulate a diverse spectrum of liver functions. Deregulation of miRNA expression may be a key pathogenetic factor in many liver diseases including viral hepatitis, hepatocellular cancer and polycystic liver diseases. A clearer understanding of the mechanisms involved in miRNA deregulation will offer new diagnostic and therapeutic strategies to treat liver diseases. Moreover, better understanding of miRNA regulation and identification of tissue-specific miRNA targets employing transgenic/knockout models and/or modulating oligonucleotides will improve our knowledge of liver physiology and diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19360909      PMCID: PMC2668771          DOI: 10.3748/wjg.15.1665

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  61 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

3.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

4.  Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes.

Authors:  Scott Baskerville; David P Bartel
Journal:  RNA       Date:  2005-03       Impact factor: 4.942

5.  Structure and expression of hcr, a locus rearranged with c-myc in a woodchuck hepatocellular carcinoma.

Authors:  T Möröy; J Etiemble; L Bougueleret; M Hadchouel; P Tiollais; M A Buendia
Journal:  Oncogene       Date:  1989-01       Impact factor: 9.867

6.  Intronic microRNAs.

Authors:  Shao-Yao Ying; Shi-Lung Lin
Journal:  Biochem Biophys Res Commun       Date:  2005-01-21       Impact factor: 3.575

7.  Integration of woodchuck hepatitis and N-myc rearrangement determine size and histologic grade of hepatic tumors.

Authors:  James R Jacob; Agnes Sterczer; Ilia A Toshkov; Amy E Yeager; Brent E Korba; Paul J Cote; Marie-Annick Buendia; John L Gerin; Bud C Tennant
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

8.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

9.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

10.  Individual mRNA expression profiles reveal the effects of specific microRNAs.

Authors:  Amit Arora; David Ac Simpson
Journal:  Genome Biol       Date:  2008-05-16       Impact factor: 13.583

View more
  51 in total

1.  Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma.

Authors:  Zehra Oksuz; Mehmet Sami Serin; Engin Kaplan; Aylin Dogen; Seda Tezcan; Gonul Aslan; Gurol Emekdas; Orhan Sezgin; Engin Altintas; Eyup Naci Tiftik
Journal:  Mol Biol Rep       Date:  2014-11-13       Impact factor: 2.316

2.  MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasis.

Authors:  M Lucrecia Alvarez; Mahdieh Khosroheidari; Elena Eddy; Stefania C Done
Journal:  Atherosclerosis       Date:  2015-08-20       Impact factor: 5.162

3.  Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.

Authors:  Ashley M Lakner; Nury M Steuerwald; Tracy L Walling; Sriparna Ghosh; Ting Li; Iain H McKillop; Mark W Russo; Herbert L Bonkovsky; Laura W Schrum
Journal:  Hepatology       Date:  2012-06-18       Impact factor: 17.425

4.  Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.

Authors:  Keun Hur; Yuji Toiyama; Aaron J Schetter; Yoshinaga Okugawa; Curtis C Harris; C Richard Boland; Ajay Goel
Journal:  J Natl Cancer Inst       Date:  2015-02-06       Impact factor: 13.506

5.  MicroRNAs in hepatic pathophysiology in diabetes.

Authors:  Kirandeep Kaur; Himanshi Bhatia; Malabika Datta
Journal:  World J Diabetes       Date:  2011-10-15

6.  Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.

Authors:  Abdel-Rahman Nabawy Zekri; Amira Salah El-Din Youssef; Eman Desouky El-Desouky; Ola Sayed Ahmed; Mai M Lotfy; Auhood Abdel-Monem Nassar; Abeer A Bahnassey
Journal:  Tumour Biol       Date:  2016-06-06

7.  MicroRNAs and Malaria - A Dynamic Interaction Still Incompletely Understood.

Authors:  Amy Cohen; Valéry Combes; Georges Er Grau
Journal:  J Neuroinfect Dis       Date:  2015-03

8.  A G-quadruplex DNA-based, label-free and ultrasensitive strategy for microRNA detection.

Authors:  Li Yan; Yiyong Yan; Lei Pei; Wei Wei; Jing Zhao
Journal:  Sci Rep       Date:  2014-12-10       Impact factor: 4.379

9.  Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma.

Authors:  J Qi; J Wang; H Katayama; S Sen; S M Liu
Journal:  Neoplasma       Date:  2013       Impact factor: 2.575

10.  Thyroid hormone may regulate mRNA abundance in liver by acting on microRNAs.

Authors:  Hongyan Dong; Martin Paquette; Andrew Williams; R Thomas Zoeller; Mike Wade; Carole Yauk
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.